Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Themis Medicare Limited ( (IN:THEMISMED) ) has provided an announcement.
Themis Medicare Limited has announced the completion of a postal ballot process, conducted through remote e-voting, to seek shareholder approval on various business resolutions. The company reported that all resolutions detailed in the February 25, 2026 postal ballot notice were passed with the requisite majority, and the scrutinizer’s report and voting results have been filed with the stock exchanges and made available on its website.
This outcome reinforces the company’s corporate governance processes and indicates shareholder support for the board’s proposed actions, which may influence future strategic and operational decisions. By formally disclosing the voting results in line with SEBI’s listing regulations, Themis Medicare underscores its compliance commitments and provides transparency to investors and other market participants.
More about Themis Medicare Limited
Themis Medicare Limited is an Indian pharmaceutical company focused on developing, manufacturing, and marketing medicinal products. Headquartered in Mumbai with a registered office in Vapi, Gujarat, the company is listed on BSE and NSE under the scrip code 530199 and symbol THEMISMED, serving domestic and potentially international healthcare markets.
Average Trading Volume: 6,629
Technical Sentiment Signal: Sell
Current Market Cap: 6.42B INR
Find detailed analytics on THEMISMED stock on TipRanks’ Stock Analysis page.